IL126381A - Heterocyclic azahexane derivatives and antiviral compositions containing them - Google Patents

Heterocyclic azahexane derivatives and antiviral compositions containing them

Info

Publication number
IL126381A
IL126381A IL12638197A IL12638197A IL126381A IL 126381 A IL126381 A IL 126381A IL 12638197 A IL12638197 A IL 12638197A IL 12638197 A IL12638197 A IL 12638197A IL 126381 A IL126381 A IL 126381A
Authority
IL
Israel
Prior art keywords
compositions containing
antiviral compositions
heterocyclic
azahexane derivatives
heterocyclic azahexane
Prior art date
Application number
IL12638197A
Other languages
English (en)
Other versions
IL126381A0 (en
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27171723&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL126381(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IL126381A0 publication Critical patent/IL126381A0/xx
Publication of IL126381A publication Critical patent/IL126381A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/02—Compounds containing any of the groups, e.g. carbazates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/02—Compounds containing any of the groups, e.g. carbazates
    • C07C281/04—Compounds containing any of the groups, e.g. carbazates the other nitrogen atom being further doubly-bound to a carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
IL12638197A 1996-04-22 1997-04-14 Heterocyclic azahexane derivatives and antiviral compositions containing them IL126381A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH101896 1996-04-22
CH2997 1997-01-08
CH22397 1997-01-31
PCT/EP1997/001860 WO1997040029A1 (fr) 1996-04-22 1997-04-14 Derives d'azahexane heterocycliques a activite antivirale

Publications (2)

Publication Number Publication Date
IL126381A0 IL126381A0 (en) 1999-05-09
IL126381A true IL126381A (en) 2001-08-26

Family

ID=27171723

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12638197A IL126381A (en) 1996-04-22 1997-04-14 Heterocyclic azahexane derivatives and antiviral compositions containing them

Country Status (27)

Country Link
EP (1) EP0900210B1 (fr)
JP (1) JP3174347B2 (fr)
CN (3) CN1310905C (fr)
AR (1) AR006720A1 (fr)
AT (1) ATE288903T1 (fr)
AU (1) AU706183B2 (fr)
BR (1) BR9701877A (fr)
CA (3) CA2510945C (fr)
CY (1) CY2596B2 (fr)
CZ (1) CZ296135B6 (fr)
DE (2) DE69732483T2 (fr)
DK (1) DK0900210T3 (fr)
EA (1) EA001794B1 (fr)
ES (1) ES2238720T3 (fr)
FR (1) FR05C0030I2 (fr)
HU (1) HU224125B1 (fr)
IL (1) IL126381A (fr)
LU (1) LU91189I2 (fr)
MY (1) MY114457A (fr)
NL (1) NL300203I2 (fr)
NO (2) NO313330B1 (fr)
NZ (3) NZ509045A (fr)
PT (1) PT900210E (fr)
SI (1) SI0900210T1 (fr)
SK (1) SK285048B6 (fr)
TW (1) TW409125B (fr)
WO (1) WO1997040029A1 (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087383A (en) * 1998-01-20 2000-07-11 Bristol-Myers Squibb Company Bisulfate salt of HIV protease inhibitor
WO1999059994A1 (fr) * 1998-05-15 1999-11-25 Abbott Laboratories Composes inhibiteurs de proteases retrovirales
US6251906B1 (en) 1998-05-15 2001-06-26 Abbott Laboratories Retroviral protease inhibiting compounds
EP0976736A1 (fr) * 1998-07-29 2000-02-02 SUMIKA FINE CHEMICALS Co., Ltd. Méthode pour la production de 2-(p-alkylphényl)pyridine
ATE239707T1 (de) * 1998-08-07 2003-05-15 Sumika Fine Chemicals Co Ltd 2-phenylpyridine-derivate und verfahren zu deren herstellung
US6197803B1 (en) 1998-12-09 2001-03-06 American Home Products Corporation Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
US6207715B1 (en) 1998-12-09 2001-03-27 American Home Products Corporation Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a substituted phenylene-diamine group
US6255349B1 (en) 1998-12-09 2001-07-03 American Home Products Corporation Alph-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group
US6335350B1 (en) 1998-12-09 2002-01-01 American Home Products Corporation Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
JP4222671B2 (ja) 1999-02-15 2009-02-12 住友化学株式会社 ヒドラジン誘導体の製造方法
IT1313664B1 (it) * 1999-10-12 2002-09-09 Norpharma S P A Processo per la preparazione di un composto aril-piridinico.
JP4278316B2 (ja) * 2000-07-14 2009-06-10 住友化学株式会社 ヒドラジン誘導体の製造方法
US6365745B1 (en) 2000-07-14 2002-04-02 Sumika Fine Chemicals Co., Ltd. Method for producing hydrazine derivative
EP1546106A1 (fr) 2002-10-02 2005-06-29 Euticals Prime European Therapeutical S.P.A Procede pour la preparation de composes d'aryl-piridyle
US7943593B2 (en) * 2002-12-06 2011-05-17 Vertex Pharmaceuticals Incorporated Compositions comprising inhibitors of IMPDH enzyme
ITMI20032338A1 (it) * 2003-11-28 2005-05-29 Dinamite Dipharma S P A In Forma A Bbreviata Diph Composti feniltetrazolici.
CN1980666B (zh) * 2004-05-04 2011-03-30 布里斯托尔-迈尔斯斯奎布公司 制备阿扎那韦硫酸氢盐的方法和新的形式
KR20070110847A (ko) 2005-02-10 2007-11-20 메디비르 아베 Ｈｉｖ 프로테아제 억제제
PT2069303E (pt) * 2006-07-21 2016-06-08 Gilead Sciences Inc Inibidores de protease antiviral
MX2009013565A (es) * 2007-06-12 2010-06-02 Concert Pharmaceuticals Inc Derivados de azapeptidos.
WO2009130534A1 (fr) * 2008-04-24 2009-10-29 Oxyrane (Pty) Ltd. Procédé de synthèse d'atazanavir
EP2272830A1 (fr) * 2009-06-18 2011-01-12 Esteve Química, S.A. Procédé de préparation d'un dérivé d'azahexane hétérocyclique antiviral
EP2272831A1 (fr) 2009-06-26 2011-01-12 Prime European Therapeuticals S.p.A. Procédé pour la préparation de composés d'arylpyridinyl
WO2011037467A1 (fr) 2009-09-28 2011-03-31 Stichting Katholieke Universiteit Atazanavir pour le traitement de maladies inflammatoires
WO2011080562A1 (fr) 2009-12-29 2011-07-07 Hetero Research Foundation Nouveau aza-peptides contenant du cyclobutyl 2,2-disubstitué et/ou des dérivés alcoxy benzyle substitués comme agents antiviraux
EP2542527A2 (fr) * 2010-03-01 2013-01-09 Lupin Limited Procédé pour la préparation de sulfate d'atazanavir sensiblement exempt de diastéréomères
CA2849546A1 (fr) 2010-09-28 2012-04-05 Ratiopharm Gmbh Traitement par voie seche de l'atazanavir
WO2013014633A1 (fr) * 2011-07-27 2013-01-31 Ranbaxy Laboratories Limited Procédé de préparation d'atazanavir ou de son sel bisulfate
US9227990B2 (en) 2012-10-29 2016-01-05 Cipla Limited Antiviral phosphonate analogues and process for preparation thereof
CN104250224A (zh) * 2013-06-28 2014-12-31 上海威智医药科技有限公司 阿扎那韦富马酸盐及其制备和应用
CN104163787A (zh) * 2014-08-08 2014-11-26 山东威智医药工业有限公司 阿扎那韦及其硫酸盐的制备方法
CN107459496B (zh) * 2016-06-03 2022-07-19 华东理工大学 噻唑类衍生物在治疗病毒感染中的应用
UY37592A (es) 2017-02-06 2018-08-31 Gilead Sciences Inc Compuestos inhibidores del vih
CN107245052A (zh) * 2017-06-21 2017-10-13 连云港杰瑞药业有限公司 一种阿扎那韦制备方法
TWI829205B (zh) * 2018-07-30 2024-01-11 美商基利科學股份有限公司 抗hiv化合物
CN109251165B (zh) * 2018-10-02 2022-09-23 国药集团川抗制药有限公司 阿扎那韦达二4-氨基苯磺酸盐及其制备方法
CN109574916A (zh) * 2018-12-29 2019-04-05 常州吉恩药业有限公司 阿扎那韦中间体2-[4-(2-吡啶基)苄基]-肼羧酸叔丁酯的工业化生产方法
WO2021209563A1 (fr) 2020-04-16 2021-10-21 Som Innovation Biotech, S.A. Composés destinés à être utilisés dans le traitement d'infections virales par un coronavirus associé au syndrome respiratoire
CN113603634B (zh) * 2021-08-06 2023-03-21 江苏八巨药业有限公司 一种阿扎那韦中间体的制备方法
CN116987024B (zh) * 2023-08-01 2026-02-13 浙江荣耀生物科技股份有限公司 一种阿扎那韦中间体的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE913840A1 (en) * 1990-11-20 1992-05-20 Abbott Lab Retroviral protease inhibiting compounds
ATE143355T1 (de) * 1991-07-03 1996-10-15 Ciba Geigy Ag Pharmakologisch wirksame hydrazinderivate und verfahren zu deren herstellung
ES2093394T3 (es) * 1992-12-23 1996-12-16 Ciba Geigy Ag Derivados de hidrazina antiretrovirales.
DE69334250D1 (de) * 1992-12-29 2009-01-29 Abbott Lab Verfahren und Intermediate zur Herstellung von retroviralen Proteasehemmern
US5461067A (en) * 1993-02-25 1995-10-24 Abbott Laboratories Retroviral protease inhibiting compounds
US6451973B1 (en) 1996-07-17 2002-09-17 Novatis Ag Anilinopeptide derivatives

Also Published As

Publication number Publication date
CA2510945C (fr) 2007-01-16
NL300203I1 (nl) 2005-10-03
CY2596B2 (en) 2010-03-03
JPH11511177A (ja) 1999-09-28
DE69732483D1 (de) 2005-03-17
HUP9901612A3 (en) 2000-06-28
CA2250840C (fr) 2006-07-04
CA2568104C (fr) 2009-08-04
NZ509046A (en) 2002-05-31
CN1310905C (zh) 2007-04-18
WO1997040029A1 (fr) 1997-10-30
NZ332118A (en) 2001-02-23
CZ296135B6 (cs) 2006-01-11
CN1082508C (zh) 2002-04-10
LU91189I9 (fr) 2018-12-27
HK1075043A1 (en) 2005-12-02
LU91189I2 (fr) 2005-10-03
DE69732483T2 (de) 2005-07-28
NO984900D0 (no) 1998-10-21
NO313330B1 (no) 2002-09-16
CA2250840A1 (fr) 1997-10-30
EP0900210A1 (fr) 1999-03-10
BR9701877A (pt) 1998-09-29
AR006720A1 (es) 1999-09-08
CN1193010C (zh) 2005-03-16
NZ509045A (en) 2002-09-27
IL126381A0 (en) 1999-05-09
DK0900210T3 (da) 2005-05-02
FR05C0030I2 (fr) 2007-04-27
SK285048B6 (sk) 2006-05-04
FR05C0030I1 (fr) 2005-08-12
MY114457A (en) 2002-10-31
AU706183B2 (en) 1999-06-10
CN1319587A (zh) 2001-10-31
CZ337398A3 (cs) 1999-01-13
AU2385997A (en) 1997-11-12
SK145298A3 (en) 1999-06-11
SI0900210T1 (fr) 2005-08-31
JP3174347B2 (ja) 2001-06-11
NO2005010I1 (no) 2005-05-02
PT900210E (pt) 2005-06-30
NL300203I2 (nl) 2005-11-01
EA199800899A1 (ru) 1999-10-28
ATE288903T1 (de) 2005-02-15
DE122005000003I1 (de) 2005-05-25
EA001794B1 (ru) 2001-08-27
CN1616453A (zh) 2005-05-18
NO984900L (no) 1998-12-21
CA2568104A1 (fr) 1997-10-30
HK1018788A1 (en) 2000-01-07
HUP9901612A2 (hu) 1999-08-30
ES2238720T3 (es) 2005-09-01
CA2510945A1 (fr) 1997-10-30
CN1216539A (zh) 1999-05-12
EP0900210B1 (fr) 2005-02-09
HU224125B1 (hu) 2005-05-30
TW409125B (en) 2000-10-21

Similar Documents

Publication Publication Date Title
IL112249A0 (en) Heterocyclic pyrimidine derivatives and pharmaceutical compositions containing them
HUP0001154A3 (en) 3-piperidyl-4-oxoquinazoline derivatives and medicincal compositions containing the same
HUP0101172A3 (en) Ortho-anthranilamide derivatives and their use as anti-coagulants
IL123887A0 (en) Dithiolan derivatives their use and pharmaceutical compositions containing the same
HUP0001243A3 (en) Nicotinamide derivatives and pharmaceutical compositions containing them
IL123162A (en) Pyridazin-3-one derivatives and herbicidal compositions comprising them
HUP9900424A2 (hu) Tiazolil-benzfurán-származékok és a vegyületeket tartalmazó gyógyászati készítmények
GB9309716D0 (en) Heterocyclic derivatives
IL120669A0 (en) Benzylamine derivatives and pharmaceutical compositions containing them
HUP0100085A3 (en) Biphenylamidine derivatives and pharmaceutical compositions containing them
HUP9903280A3 (en) Thiophene derivatives and drug compositions containing the same
GB9408473D0 (en) Heterocyclic derivatives
EP0968983A4 (fr) Composition d' hexanitrohexaazaisowurtzitane et composition explosive la contenant
GB9311562D0 (en) Heterocyclic derivatives
IL121691A0 (en) N-benzylazolium derivatives their preparation and compositions containing them
IL113542A0 (en) Substituted hydroxybenzyl-heteroaryl derivatives compositions containing them and their use
HUP0000275A3 (en) Phenanethridinium derivatives and pharmaceutical compositions containing them
HUP9901968A3 (en) 2-thioxotetrahydropyrimidin-4-one derivatives and pharmaceutical compositions containing them
HUP0003765A3 (en) Crambescidin derivatives and pharmaceutical compositions containing them
GB9405533D0 (en) Heterocyclic derivatives
GB9623283D0 (en) Heterocyclic derivatives
GB9306453D0 (en) Heterocyclic derivatives
IL118268A0 (en) Pyrrolinone derivatives and herbicidal compositions containing the same
HUP0003827A3 (en) Cyanoamidine derivatives and pharmaceutical compositions containing them
ZA941917B (en) Nucleoside derivatives and anti-herpes composition

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
EXTP Application for extension order is pending
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired